Acquisition steps up SynTech’s UK business
“This acquisition will significantly enhance our UK operation, alongside our existing, largely continental European, GEP and GLP field trials capability,” explains Jerry Calloway, SynTech’s UK Manager. “SynTech UK will focus on seed treatment, disease control and bio-stimulant efficacy trials, and GLP residue studies, using the laboratory and glasshouse facilities at the site.”
Nicholas Burton, the previous owner of SACCS, joins SynTech UK to support further development of the site, which will be fully operational for the 2015 Autumn programme. Small plot herbicide screens and irrigated cereal foliar disease trials have already been established.
For more information:
Dr. Colin Ruscoe
SynTech Research
Tel: +44 (0) 1296 612786+44 (0) 1296 612786
Email: cruscoe@syntechresearch.com